Company · CIK 0001235010 · SIC 2836 — Biological Products, (No Diagnostic Substances)
MOMENTA PHARMACEUTICALS INC · MNTA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 23, 2016 AForm 4 → | Jun 27, 2:43 pm EDT | James R SulatDirector | 5,500 | — | — | 20,500 | — | plan? |
| Jun 23, 2016 AForm 4 → | Jun 27, 2:39 pm EDT | Elizabeth StonerDirector | 5,500 | — | — | 18,740 | — | plan? |
| Jun 23, 2016 AForm 4 → | Jun 27, 2:36 pm EDT | Thomas P KoestlerDirector | 5,500 | — | — | 5,500 | — | plan? |
| Jun 23, 2016 AForm 4 → | Jun 27, 2:31 pm EDT | Marsha FanucciDirector | 5,500 | — | — | 14,500 | — | plan? |
| Jun 23, 2016 AForm 4 → | Jun 27, 2:27 pm EDT | Bruce DowneyDirector | 5,500 | — | — | 15,500 | — | plan? |
| Jun 1, 2016 SForm 4 → | Jun 8, 3:55 pm EDT | Bennett M ShapiroDirector | 5,200 | $13.00 | $67,600 | 10,834 | −32.4% | plan? late |
| Jun 1, 2016 MForm 4 → | Jun 8, 3:55 pm EDT | Bennett M ShapiroDirector | 5,200 | $12.90 | $67,080 | 5,200 | — | plan? late |
| May 20, 2016 SForm 4 → | May 23, 4:11 pm EDT | Bruce LeicherSVP & General Counsel | 1,000 | $10.40 | $10,400 | 183,982 | −0.54% | plan? |
| May 19, 2016 SForm 4 → | May 23, 4:43 pm EDT | Craig A WheelerPresident, Director | 5,880 | $10.18 | $59,853 | 345,699 | −1.67% | plan? |
| May 19, 2016 SForm 4 → | May 23, 12:49 pm EDT | James M. RoachSenior VP, Development and Chi | 1,092 | $10.18 | $11,116 | 157,563 | −0.69% | plan? |
| May 19, 2016 SForm 4 → | May 23, 12:46 pm EDT | Ganesh Venkataraman KaundinyaSenior V.P., Research | 1,050 | $10.18 | $10,690 | 456,112 | −0.23% | plan? |
| May 19, 2016 SForm 4 → | May 23, 12:43 pm EDT | Richard P SheaSVP, CFO | 973 | $10.18 | $9,904 | 133,099 | −0.73% | plan? |
| May 19, 2016 SForm 4 → | May 23, 12:40 pm EDT | John E BishopSenior VP, Pharmaceutical Scie | 784 | $10.20 | $7,997 | 157,253 | −0.50% | plan? |
| Apr 19, 2016 SForm 4 → | Apr 19, 4:08 pm EDT | John E BishopSenior VP, Pharmaceutical Scie | 2,843 | $9.57 | $27,208 | 158,037 | −1.77% | plan? |
| Apr 18, 2016 FForm 4 → | Apr 19, 4:11 pm EDT | Craig A WheelerPresident, Director | 26,608 | $9.69 | $257,832 | 351,579 | — | plan? |
| Apr 18, 2016 FForm 4 → | Apr 19, 4:08 pm EDT | John E BishopSenior VP, Pharmaceutical Scie | 6,206 | $9.69 | $60,136 | 160,880 | — | plan? |
| Apr 18, 2016 FForm 4 → | Apr 19, 4:04 pm EDT | James M. RoachSenior VP, Development and Chi | 6,206 | $9.69 | $60,136 | 158,655 | — | plan? |
| Apr 18, 2016 FForm 4 → | Apr 19, 4:01 pm EDT | Richard P SheaSVP, CFO | 6,206 | $9.69 | $60,136 | 134,072 | — | plan? |
| Apr 18, 2016 FForm 4 → | Apr 19, 3:59 pm EDT | Ganesh Venkataraman KaundinyaSenior V.P., Research | 6,206 | $9.69 | $60,136 | 457,162 | — | plan? |
| Apr 18, 2016 FForm 4 → | Apr 19, 3:55 pm EDT | Bruce LeicherSVP & General Counsel | 6,206 | $9.69 | $60,136 | 184,982 | — | plan? |
| Apr 13, 2016 AForm 4 → | Apr 15, 2:04 pm EDT | Craig A WheelerPresident, Director | 150,000 | — | — | 378,187 | — | plan? |
| Apr 13, 2016 AForm 4 → | Apr 15, 2:00 pm EDT | Bruce LeicherSVP & General Counsel | 60,000 | — | — | 191,188 | — | plan? |
| Apr 13, 2016 AForm 4 → | Apr 15, 1:56 pm EDT | Matthew P. OttmerChief Operating Officer | 75,000 | — | — | 75,000 | — | plan? |
| Apr 13, 2016 AForm 4 → | Apr 15, 1:51 pm EDT | John E BishopSenior VP, Pharmaceutical Scie | 60,000 | — | — | 167,086 | — | plan? |
| Apr 13, 2016 AForm 4 → | Apr 15, 1:45 pm EDT | Ganesh Venkataraman KaundinyaSenior V.P., Research | 60,000 | — | — | 463,368 | — | plan? |
| Apr 13, 2016 AForm 4 → | Apr 15, 1:39 pm EDT | James M. RoachSenior VP, Development and Chi | 60,000 | — | — | 164,861 | — | plan? |
| Feb 22, 2016 SForm 4 → | Feb 24, 11:53 am EST | John E BishopSenior VP, Pharmaceutical Scie | 329 | $9.70 | $3,190 | 107,086 | −0.31% | plan? |
| Feb 22, 2016 SForm 4 → | Feb 24, 11:47 am EST | Craig A WheelerPresident, Director | 1,688 | $9.95 | $16,796 | 244,342 | −0.69% | plan? |
| Feb 22, 2016 SForm 4 → | Feb 24, 11:45 am EST | Richard P SheaSVP, CFO | 227 | $9.65 | $2,191 | 140,278 | −0.16% | plan? |
| Feb 22, 2016 SForm 4 → | Feb 24, 11:42 am EST | James M. RoachSenior VP, Development and Chi | 250 | $9.65 | $2,413 | 104,861 | −0.24% | plan? |
| Feb 22, 2016 SForm 4 → | Feb 24, 11:37 am EST | Bruce LeicherSVP & General Counsel | 227 | $9.65 | $2,191 | 131,188 | −0.17% | plan? |
| Feb 22, 2016 SForm 4 → | Feb 24, 11:34 am EST | Ganesh Venkataraman KaundinyaSenior V.P., Research | 227 | $9.65 | $2,191 | 403,368 | −0.06% | plan? |
| Feb 19, 2016 SForm 4 → | Feb 22, 12:41 pm EST | John E BishopSenior VP, Pharmaceutical Scie | 2,848 | $9.66 | $27,520 | 107,415 | −2.58% | plan? |
| Feb 19, 2016 SForm 4 → | Feb 22, 12:35 pm EST | Bruce LeicherSVP & General Counsel | 2,000 | $9.64 | $19,284 | 131,415 | −1.50% | plan? |
| Feb 19, 2016 SForm 4 → | Feb 22, 12:29 pm EST | James M. RoachSenior VP, Development and Chi | 2,158 | $9.64 | $20,807 | 105,111 | −2.01% | plan? |
| Feb 19, 2016 SForm 4 → | Feb 22, 12:25 pm EST | Ganesh Venkataraman KaundinyaSenior V.P., Research | 2,138 | $9.64 | $20,614 | 403,595 | −0.53% | plan? |
| Feb 19, 2016 SForm 4 → | Feb 22, 12:03 pm EST | Richard P SheaSVP, CFO | 1,823 | $9.64 | $17,578 | 140,505 | −1.28% | plan? |
| Feb 19, 2016 SForm 4 → | Feb 22, 11:58 am EST | Craig A WheelerPresident, Director | 9,844 | $9.37 | $92,199 | 246,030 | −3.85% | plan? |
| Feb 18, 2016 SForm 4 → | Feb 19, 2:51 pm EST | John E BishopSenior VP, Pharmaceutical Scie | 357 | $10.28 | $3,670 | 110,263 | −0.32% | plan? |
| Feb 18, 2016 SForm 4 → | Feb 19, 2:48 pm EST | Ganesh Venkataraman KaundinyaSenior V.P., Research | 272 | $10.49 | $2,853 | 405,733 | −0.07% | plan? |
| Feb 18, 2016 SForm 4 → | Feb 19, 2:45 pm EST | James M. RoachSenior VP, Development and Chi | 272 | $10.49 | $2,853 | 107,269 | −0.25% | plan? |
| Feb 18, 2016 SForm 4 → | Feb 19, 2:17 pm EST | Richard P SheaSVP, CFO | 183 | $10.49 | $1,920 | 142,328 | −0.13% | plan? |
| Feb 18, 2016 SForm 4 → | Feb 19, 2:10 pm EST | Bruce LeicherSVP & General Counsel | 337 | $10.49 | $3,535 | 133,415 | −0.25% | plan? |
| Feb 17, 2016 SForm 4 → | Feb 18, 2:50 pm EST | Craig A WheelerPresident, Director | 1,688 | $11.30 | $19,074 | 255,874 | −0.66% | plan? |
| Feb 9, 2016 AForm 4 → | Feb 11, 4:24 pm EST | Bruce LeicherSVP & General Counsel | 17,100 | — | — | 133,752 | — | plan? |
| Feb 9, 2016 AForm 4 → | Feb 11, 2:27 pm EST | Craig A WheelerPresident, Director | 63,000 | — | — | 257,562 | — | plan? |
| Feb 9, 2016 AForm 4 → | Feb 11, 2:23 pm EST | John E BishopSenior VP, Pharmaceutical Scie | 17,100 | — | — | 110,620 | — | plan? |
| Feb 9, 2016 SForm 4 → | Feb 11, 2:13 pm EST | James M. RoachSenior VP, Development and Chi | 17,100 | — | — | 107,541 | — | plan? |
| Feb 9, 2016 AForm 4 → | Feb 11, 2:06 pm EST | Ganesh Venkataraman KaundinyaSenior V.P., Research | 18,900 | — | — | 406,005 | — | plan? |
| Dec 11, 2015 SForm 4 → | Dec 14, 11:16 am EST | Michael FrankenPresident, Biosimilars Busines | 520 | $15.84 | $8,237 | 37,968 | −1.35% | plan? |
| Nov 20, 2015 SForm 4 → | Nov 23, 3:14 pm EST | John E BishopSenior VP, Pharmaceutical Scie | 548 | $17.77 | $9,740 | 93,520 | −0.58% | plan? |
| Nov 20, 2015 SForm 4 → | Nov 23, 3:11 pm EST | Ganesh Venkataraman KaundinyaSenior V.P., Research | 227 | $17.75 | $4,029 | 387,105 | −0.06% | plan? |
| Nov 20, 2015 SForm 4 → | Nov 23, 3:06 pm EST | James M. RoachSenior VP, Development and Chi | 360 | $17.75 | $6,390 | 90,441 | −0.40% | plan? |
| Nov 20, 2015 SForm 4 → | Nov 23, 3:02 pm EST | Craig A WheelerPresident, Director | 1,766 | $17.86 | $31,541 | 200,844 | −0.87% | plan? |
| Nov 20, 2015 SForm 4 → | Nov 23, 3:00 pm EST | Richard P SheaSVP, CFO | 227 | $17.75 | $4,029 | 142,511 | −0.16% | plan? |
| Nov 20, 2015 SForm 4 → | Nov 23, 1:47 pm EST | Bruce LeicherSVP & General Counsel | 328 | $17.75 | $5,822 | 116,082 | −0.28% | plan? |
| Nov 19, 2015 SForm 4 → | Nov 20, 2:16 pm EST | Ganesh Venkataraman KaundinyaSenior V.P., Research | 397 | $18.17 | $7,213 | 387,332 | −0.10% | plan? |
| Nov 19, 2015 SForm 4 → | Nov 20, 2:12 pm EST | James M. RoachSenior VP, Development and Chi | 603 | $18.17 | $10,957 | 90,801 | −0.66% | plan? |
| Nov 19, 2015 SForm 4 → | Nov 20, 2:07 pm EST | Craig A WheelerPresident, Director | 2,061 | $18.05 | $37,201 | 202,610 | −1.01% | plan? |
| Nov 19, 2015 SForm 4 → | Nov 20, 2:05 pm EST | Richard P SheaSVP, CFO | 397 | $18.17 | $7,213 | 142,738 | −0.28% | plan? |
| Nov 19, 2015 SForm 4 → | Nov 20, 11:05 am EST | Bruce LeicherSVP & General Counsel | 603 | $18.17 | $10,957 | 116,410 | −0.52% | plan? |
| Nov 18, 2015 SForm 4 → | Nov 20, 2:01 pm EST | John E BishopSenior VP, Pharmaceutical Scie | 650 | $18.12 | $11,775 | 94,068 | −0.69% | plan? |
| Nov 17, 2015 SForm 4 → | Nov 18, 4:39 pm EST | John E BishopSenior VP, Pharmaceutical Scie | 312 | $17.65 | $5,507 | 94,718 | −0.33% | plan? |
| Nov 17, 2015 SForm 4 → | Nov 18, 4:37 pm EST | Craig A WheelerPresident, Director | 1,766 | $17.70 | $31,258 | 204,671 | −0.86% | plan? |
| Nov 17, 2015 SForm 4 → | Nov 18, 4:32 pm EST | James M. RoachSenior VP, Development and Chi | 312 | $17.65 | $5,507 | 91,404 | −0.34% | plan? |
| Nov 17, 2015 SForm 4 → | Nov 18, 4:04 pm EST | Bruce LeicherSVP & General Counsel | 387 | $17.65 | $6,831 | 117,013 | −0.33% | plan? |
| Nov 17, 2015 SForm 4 → | Nov 18, 3:17 pm EST | Ganesh Venkataraman KaundinyaSenior V.P., Research | 216 | $17.65 | $3,812 | 387,729 | −0.06% | plan? |
| Nov 17, 2015 SForm 4 → | Nov 18, 3:11 pm EST | Richard P SheaSVP, CFO | 145 | $17.65 | $2,559 | 143,135 | −0.10% | plan? |
| Nov 5, 2015 SForm 4 → | Nov 6, 3:24 pm EST | Craig A WheelerPresident, Director | 51,667 | $18.00 | $930,006 | 177,314 | −22.6% | plan? |
| Nov 5, 2015 MForm 4 → | Nov 6, 3:24 pm EST | Craig A WheelerPresident, Director | 41,667 | $16.18 | $674,172 | 248,104 | — | plan? |
| Sep 11, 2015 SForm 4 → | Sep 15, 11:15 am EDT | Michael FrankenPresident, Biosimilars Busines | 513 | $18.92 | $9,706 | 38,488 | −1.32% | plan? |
| Aug 20, 2015 SForm 4 → | Aug 24, 3:33 pm EDT | Bruce LeicherSVP & General Counsel | 330 | $22.20 | $7,326 | 117,400 | −0.28% | plan? |
| Aug 20, 2015 SForm 4 → | Aug 24, 2:30 pm EDT | John E BishopSenior VP, Pharmaceutical Scie | 549 | $21.88 | $12,015 | 95,030 | −0.57% | plan? |
| Aug 20, 2015 SForm 4 → | Aug 24, 2:26 pm EDT | James M. RoachSenior VP, Development and Chi | 363 | $22.20 | $8,059 | 91,716 | −0.39% | plan? |
| Aug 20, 2015 SForm 4 → | Aug 24, 2:21 pm EDT | Ganesh Venkataraman KaundinyaSenior V.P., Research | 228 | $22.20 | $5,062 | 387,945 | −0.06% | plan? |
| Aug 20, 2015 SForm 4 → | Aug 24, 2:12 pm EDT | Richard P SheaSVP, CFO | 228 | $22.20 | $5,062 | 143,280 | −0.16% | plan? |
| Aug 20, 2015 SForm 4 → | Aug 24, 2:09 pm EDT | Craig A WheelerPresident, Director | 1,766 | $22.28 | $39,346 | 212,719 | −0.82% | plan? |
| Aug 19, 2015 SForm 4 → | Aug 20, 10:10 am EDT | John E BishopSenior VP, Pharmaceutical Scie | 573 | $22.00 | $12,606 | 95,579 | −0.60% | plan? |
| Aug 19, 2015 SForm 4 → | Aug 20, 10:06 am EDT | James M. RoachSenior VP, Development and Chi | 7,011 | $22.09 | $154,883 | 92,079 | −7.08% | plan? |
| Aug 19, 2015 SForm 4 → | Aug 20, 9:58 am EDT | Bruce LeicherSVP & General Counsel | 601 | $22.00 | $13,222 | 117,730 | −0.51% | plan? |
| Aug 19, 2015 SForm 4 → | Aug 20, 9:56 am EDT | Craig A WheelerPresident, Director | 2,061 | $22.02 | $45,383 | 214,485 | −0.95% | plan? |
| Aug 19, 2015 SForm 4 → | Aug 20, 9:51 am EDT | Richard P SheaSVP, CFO | 396 | $22.00 | $8,712 | 143,508 | −0.28% | plan? |
| Aug 19, 2015 SForm 4 → | Aug 20, 9:48 am EDT | Ganesh Venkataraman KaundinyaSenior V.P., Research | 396 | $22.00 | $8,712 | 388,173 | −0.10% | plan? |
| Aug 17, 2015 SForm 4 → | Aug 19, 4:53 pm EDT | John E BishopSenior VP, Pharmaceutical Scie | 3,228 | $21.79 | $70,345 | 96,152 | −3.25% | plan? |
| Aug 17, 2015 SForm 4 → | Aug 19, 3:45 pm EDT | James M. RoachSenior VP, Development and Chi | 6,812 | $21.80 | $148,526 | 99,090 | −6.43% | plan? |
| Aug 17, 2015 SForm 4 → | Aug 19, 3:18 pm EDT | Craig A WheelerPresident, Director | 1,766 | $21.77 | $38,446 | 216,546 | −0.81% | plan? |
| Aug 17, 2015 SForm 4 → | Aug 19, 3:15 pm EDT | Richard P SheaSVP, CFO | 144 | $21.67 | $3,120 | 143,904 | −0.10% | plan? |
| Aug 17, 2015 SForm 4 → | Aug 19, 3:11 pm EDT | Ganesh Venkataraman KaundinyaSenior V.P., Research | 216 | $21.67 | $4,681 | 388,569 | −0.06% | plan? |
| Aug 17, 2015 SForm 4 → | Aug 19, 1:33 pm EDT | Bruce LeicherSVP & General Counsel | 386 | $21.67 | $8,365 | 118,331 | −0.33% | plan? |
| Aug 10, 2015 SForm 4 → | Aug 14, 12:43 pm EDT | Michael FrankenPresident, Biosimilars Busines | 20,000 | $22.36 | $447,200 | 39,001 | −33.9% | plan? late |
| Aug 10, 2015 MForm 4 → | Aug 14, 12:43 pm EDT | Michael FrankenPresident, Biosimilars Busines | 20,000 | $17.23 | $344,600 | 59,001 | — | plan? late |
| Jul 15, 2015 SForm 4 → | Jul 16, 2:58 pm EDT | Elizabeth StonerDirector | 4,570 | $22.35 | $102,140 | 13,240 | −25.7% | plan? |
| Jul 15, 2015 MForm 4 → | Jul 16, 2:58 pm EDT | Elizabeth StonerDirector | 6,667 | $8.33 | $55,569 | 16,724 | — | plan? |
| Jun 19, 2015 SForm 4 → | Jun 22, 4:24 pm EDT | John E BishopSenior VP, Pharmaceutical Scie | 21,274 | $25.50 | $542,487 | 99,380 | −17.6% | plan? |
| Jun 19, 2015 MForm 4 → | Jun 22, 4:24 pm EDT | John E BishopSenior VP, Pharmaceutical Scie | 21,274 | $15.44 | $328,471 | 118,100 | — | plan? |
| Jun 18, 2015 SForm 4 → | Jun 22, 4:17 pm EDT | Craig A WheelerPresident, Director | 155,000 | $24.20 | $3,750,800 | 181,032 | −46.1% | plan? |
| Jun 18, 2015 MForm 4 → | Jun 22, 4:17 pm EDT | Craig A WheelerPresident, Director | 125,000 | $16.18 | $2,022,500 | 343,312 | — | plan? |
| Jun 18, 2015 SForm 4 → | Jun 22, 2:19 pm EDT | Bruce LeicherSVP & General Counsel | 20,000 | $23.00 | $460,000 | 117,817 | −14.5% | plan? |
| Jun 18, 2015 MForm 4 → | Jun 22, 2:19 pm EDT | Bruce LeicherSVP & General Counsel | 20,000 | $15.12 | $302,400 | 124,269 | — | plan? |
| Jun 18, 2015 SForm 4 → | Jun 19, 4:04 pm EDT | James M. RoachSenior VP, Development and Chi | 25,000 | $23.70 | $592,500 | 105,902 | −19.1% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 23, 2016 AForm 4 → | Jun 27, 2:27 pm EDT | Bruce DowneyDirector | 11,000 | — | — | 11,000 | — | |
| Jun 22, 2016 AForm 4 → | Jun 24, 3:25 pm EDT | Steven C GilmanDirector | 33,000 | — | — | 33,000 | — | |
| Jun 1, 2016 MForm 4 → | Jun 8, 3:55 pm EDT | Bennett M ShapiroDirector | 5,200 | $12.90 | $67,080 | 14,000 | — | late |
| Mar 9, 2016 AForm 4 → | Mar 11, 1:17 pm EST | Jose-Carlos Gutierrez-RamosDirector | 30,000 | — | — | 30,000 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 4:24 pm EST | Bruce LeicherSVP & General Counsel | 34,200 | — | — | 34,200 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 2:27 pm EST | Craig A WheelerPresident, Director | 126,000 | — | — | 126,000 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 2:23 pm EST | John E BishopSenior VP, Pharmaceutical Scie | 34,200 | — | — | 34,200 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 2:13 pm EST | James M. RoachSenior VP, Development and Chi | 34,200 | — | — | 34,200 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 2:06 pm EST | Ganesh Venkataraman KaundinyaSenior V.P., Research | 37,800 | — | — | 37,800 | — | |
| Jan 1, 2016 AForm 4 → | Jan 5, 1:35 pm EST | Georges GemayelDirector | 30,000 | — | — | 30,000 | — | |
| Dec 10, 2015 AForm 4 → | Dec 14, 4:57 pm EST | Matthew P. OttmerChief Operating Officer | 175,000 | — | — | 175,000 | — | |
| Nov 5, 2015 MForm 4 → | Nov 6, 3:24 pm EST | Craig A WheelerPresident, Director | 41,667 | — | — | 83,333 | — | |
| Aug 10, 2015 MForm 4 → | Aug 14, 12:43 pm EDT | Michael FrankenPresident, Biosimilars Busines | 20,000 | — | — | 50,000 | — | late |
| Jul 15, 2015 MForm 4 → | Jul 16, 2:58 pm EDT | Elizabeth StonerDirector | 6,667 | — | — | 10,000 | — | |
| Jun 19, 2015 MForm 4 → | Jun 22, 4:24 pm EDT | John E BishopSenior VP, Pharmaceutical Scie | 21,274 | — | — | 0 | — | |
| Jun 18, 2015 MForm 4 → | Jun 22, 4:17 pm EDT | Craig A WheelerPresident, Director | 125,000 | — | — | 125,000 | — | |
| Jun 18, 2015 MForm 4 → | Jun 22, 2:19 pm EDT | Bruce LeicherSVP & General Counsel | 20,000 | — | — | 0 | — | |
| Jun 18, 2015 MForm 4 → | Jun 19, 4:04 pm EDT | James M. RoachSenior VP, Development and Chi | 25,000 | — | — | 47,500 | — | |
| Jun 17, 2015 MForm 4 → | Jun 19, 4:00 pm EDT | John E BishopSenior VP, Pharmaceutical Scie | 25,313 | — | — | 0 | — | |
| Jun 10, 2015 AForm 4 → | Jun 11, 12:00 pm EDT | James R SulatDirector | 17,750 | — | — | 133,750 | — | |
| Jun 10, 2015 AForm 4 → | Jun 11, 11:55 am EDT | John K ClarkeDirector | 17,750 | — | — | 176,350 | — | |
| Jun 10, 2015 AForm 4 → | Jun 11, 11:51 am EDT | Marsha FanucciDirector | 17,750 | — | — | 176,350 | — | |
| Jun 10, 2015 AForm 4 → | Jun 11, 11:48 am EDT | Thomas P KoestlerDirector | 17,750 | — | — | 101,000 | — | |
| Jun 10, 2015 AForm 4 → | Jun 11, 11:40 am EDT | Elizabeth StonerDirector | 17,750 | — | — | 139,617 | — | |
| Jun 10, 2015 AForm 4 → | Jun 11, 11:16 am EDT | Bennett M ShapiroDirector | 17,750 | — | — | 161,350 | — | |
| Jun 10, 2015 AForm 4 → | Jun 11, 11:11 am EDT | Bruce DowneyDirector | 17,750 | — | — | 123,750 | — | |
| Jun 4, 2015 MForm 4 → | Jun 5, 1:53 pm EDT | Craig A WheelerPresident, Director | 83,333 | — | — | 250,000 | — | |
| Jun 1, 2015 MForm 4 → | Jun 2, 3:54 pm EDT | Bruce LeicherSVP & General Counsel | 40,000 | — | — | 20,000 | — | |
| Jun 1, 2015 MForm 4 → | Jun 2, 3:46 pm EDT | James M. RoachSenior VP, Development and Chi | 25,000 | — | — | 72,500 | — | |
| May 12, 2015 MForm 4 → | May 14, 3:17 pm EDT | John K ClarkeDirector | 38,400 | — | — | 0 | — | |
| May 11, 2015 MForm 4 → | May 13, 2:33 pm EDT | John E BishopSenior VP, Pharmaceutical Scie | 33,625 | — | — | 0 | — | |
| Apr 23, 2015 MForm 4 → | Apr 27, 2:05 pm EDT | Craig A WheelerPresident, Director | 41,667 | — | — | 333,333 | — | |
| Apr 16, 2015 MForm 4 → | Apr 20, 4:26 pm EDT | James M. RoachSenior VP, Development and Chi | 50,000 | — | — | 97,500 | — | |
| Apr 16, 2015 MForm 4 → | Apr 20, 4:06 pm EDT | Bruce LeicherSVP & General Counsel | 40,000 | — | — | 43,548 | — | |
| Feb 18, 2015 AForm 4 → | Feb 20, 3:04 pm EST | Richard P SheaSVP, CFO | 33,953 | $13.02 | $442,068 | 260,056 | — | |
| Feb 18, 2015 AForm 4 → | Feb 20, 3:04 pm EST | Michael FrankenPresident, Biosimilars Busines | 33,953 | $13.02 | $442,068 | 103,953 | — | |
| Feb 18, 2015 AForm 4 → | Feb 20, 3:03 pm EST | John E BishopSenior VP, Pharmaceutical Scie | 37,725 | $13.02 | $491,180 | 223,671 | — | |
| Feb 18, 2015 AForm 4 → | Feb 20, 3:03 pm EST | Ganesh Venkataraman KaundinyaSenior V.P., Research | 41,498 | $13.02 | $540,304 | 253,676 | — | |
| Feb 18, 2015 AForm 4 → | Feb 20, 3:02 pm EST | James M. RoachSenior VP, Development and Chi | 41,498 | $13.02 | $540,304 | 352,413 | — | |
| Feb 18, 2015 AForm 4 → | Feb 20, 3:02 pm EST | Craig A WheelerPresident, Director | 140,000 | $13.02 | $1,822,800 | 1,332,000 | — | |
| Feb 18, 2015 AForm 4 → | Feb 19, 3:42 pm EST | Bruce LeicherSVP & General Counsel | 37,725 | $13.02 | $491,180 | 283,157 | — | |
| Feb 11, 2015 MForm 4 → | Feb 12, 3:41 pm EST | Bruce DowneyDirector | 10,000 | $8.85 | $88,500 | 106,000 | — | |
| Jan 16, 2015 MForm 4 → | Jan 20, 3:53 pm EST | Richard P SheaSVP, CFO | 11,250 | $6.88 | $77,400 | 226,103 | — |